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Peripheral nerve regeneration remains a significant clinical challenge due to the unsatisfactory functional re
covery and public health burden. Exosomes, especially those derived from mesenchymal stem cells (MSCs), are
promising as potential cell-free therapeutics and gene therapy vehicles for promoting neural regeneration. In this
study, we reported the differentiation of human adipose derived MSCs (hADMSCs) towards the Schwann cell (SC)
phenotype (hADMSC-SCs) and then isolated exosomes from hADMSCs with and without differentiation (i.e.,
dExo vs uExo). We assessed and compared the effects of uExo and dExo on antioxidative, angiogenic, antiinflammatory, and axon growth promoting properties by using various peripheral nerve-related cells. Our re
sults demonstrated that hADMSC-SCs secreted more neurotrophic factors and other growth factors, compared to
hADMSCs without differentiation. The dExo isolated from hADMSC-SCs protected rat SCs from oxidative stress
and enhanced HUVEC migration and angiogenesis. Compared to uExo, dExo also had improved performances in
downregulating pro-inflammatory gene expressions and cytokine secretions and promoting axonal growth of
sensory neurons differentiated from human induced pluripotent stem cells. Furthermore, microRNA (miRNA)
sequencing analysis revealed that exosomes and their parent cells shared some similarities in their miRNA
profiles and exosomes displayed a distinct miRNA signature. Many more miRNAs were identified in dExo than in
uExo. Several upregulated miRNAs, like miRNA-132-3p and miRNA-199b-5p, were highly related to neuro
protection, anti-inflammation, and angiogenesis. The dExo can effectively modulate various peripheral nerverelated cellular functions and is promising for cell-free biological therapeutics to enhance neural regeneration.

1. Instruction
Peripheral nerve diseases and injuries cause substantial clinical
problems and public health burden due to poor functional recovery
[1–3]. To create new therapies that promote complete nerve regenera
tion, many research projects focus on strategies that could potentially

aid regeneration and lead to clinical breakthroughs, such as increasing
neuron survival, improving the rate of axon outgrowth, and improving
the extensive growth ability of axons to overcome inhibitory signals [4,
5]. However, the effective functional recovery remains insufficient and
unsatisfactory, especially for severely damaged peripheral nerves [1,4,6,
7]. This situation has prompted the application of stem cell-based
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therapies to improve the function of peripheral nerve-related cells under
injury and pathological conditions.
Mesenchymal stem cells (MSCs) are multipotent stem cells and can
be isolated from various tissues, such as bone marrow, the umbilical
cord, and adipose tissue [8,9]. In recent years, MSCs have gradually
become one of the most promising cell therapy tools for a wide range of
injuries and diseases because of their self-renewal and differentiation
potentials, low immunogenicity, multipotency, and mediator secretion
capacity [10–13]. At the damaged site of a peripheral nerve, the im
plantation of MSCs has been reported to facilitate axonal growth and
remyelination as well as enhance angiogenesis and vascularization
[14–18]. Notably, MSCs can be differentiated into Schwann cell
(SC)-like phenotypes (MSC-SCs) by using cocktail chemical induction,
electrical stimulation, or their combinations [19–21]. Interestingly,
several studies have shown that introducing MSC-SCs promoted sciatic
nerve regeneration and functional recovery, and the regeneration effi
cacy with MSC-SCs was superior to that with acellular or MSC coun
terparts [22–24]. Currently, the mechanism of action for how exogenous
MSCs/MSC-SCs improve functional recovery is largely unknown. One
possible hypothesis is that the repair of injured peripheral nerves is
promoted via paracrine mechanisms by secreting various growth factors
and extracellular vesicles (EVs) from the incorporated MSCs/MSC-SCs
[15,25–27]. However, the differences between secretomes of MSCs
and MSC-SCs are yet to be unveiled.
Despite the ease of isolation and availability of MSCs, their differ
entiation capacity into SC-like cells, and their ability to promote axonal
regeneration all being appealing for tissue engineering, there exist sig
nificant challenges associated with maintaining cell viability and vitality
[28,29]. In addition, after transplantation in vivo, MSCs might differ
entiate into unwanted and non-peripheral nerve cell-related lineages,
such as tumorigenesis and calcification, in response to local stimuli or
other dominant cells in the area [28]. Compared to cell-based strategies,
exosomes can potentially serve as cell-free therapies, and they are more
convenient to store and transport, which helps avoid many safety risks
associated with cell transplantation [30–32]. Exosomes are nanoscale
membrane EVs with diameters ranging from 30 to 200 nm [33,34]. They
are produced and released by all types of cells via fusion of multi
vesicular bodies and the plasma membrane [35,36]. Exosomes contain
proteins, nucleic acid, and lipids, which can reflect their cell of origin
[37–39]. Exosomes also display relatively high target specificity to the
receptor cells due to their surface protein profiles [40,41]. Exosomes
play multiple roles in various biological processes through transferring
their encapsulated cargos to recipient cells [42–44]. It has been reported
that MSC-derived exosomes, either administrated alone or together with
scaffolds (depending on the animal models), promoted the recovery of
motor function and axon reconnection [25,45,46]. All these studies
demonstrate the feasibility and efficacy of the application of
MSC-derived exosomes for peripheral nerve regeneration. Exosomes
retain some of the characteristics of their parent cells. For example,
Wang et al. reported that exosomes derived from SCs, rather than fi
broblasts, promoted MSC differentiation towards SC phenotypes [47]. In
addition, Lopez-Verrilli et al. found that SC-derived exosomes markedly
facilitated neurite growth substantially and greatly enhanced axonal
regeneration in vitro and in vivo [48]. Taking the above motivations
together, MSC–SC–derived exosomes have great potential for peripheral
nerve regeneration due to the combining of MSC and SC characteristics,
which has not been reported before. Most importantly, the methods in
which the exosomes derived from MSCs with different differentiation
statuses towards SCs regulate the behaviors of peripheral nerve-related
cells are unknown, and the signature microRNA (miRNA) cargoes for
both exosomes and their parent MSCs are unrevealed.
In this study, as shown in Scheme 1, we first differentiated human
adipose derived MSCs (hADMSC) into SC-like cells and compared the
secreted growth factors with undifferentiated hADMSCs. Then, the
exosomes were isolated from supernatant media of undifferentiated and
differentiated hADMSC (denoted as uExo and dExo). Subsequently, we

Scheme 1. Exosomes (uExo and dExo) isolated from human ADMSCs and their
SC-like (hADMSC-SCs) phenotypes for regulating peripheral nerve-related
cellular functions.

explored the effects of exosomes on the modulatory functions of pe
ripheral nerve-related cells, including rat SCs (rSCs), human macro
phages, endothelial cells, and sensory neurons. Anti-oxidation and antiinflammatory effects of exosomes were evaluated using rSCs and human
monocyte derived macrophages, respectively. In addition, angiogenesis
and cell migration of human umbilical vein endothelial cells (HUVECs)
were compared after the addition of exosomes derived from MSCs with
different differentiation statuses. We also differentiated human induced
pluripotent stem cells (hiPSCs) into sensory neurons (SNs) and further
generated sensory neurospheres to study the effects of different exosome
origins on axonal growth. Furthermore, exosomal miRNA sequencing
was conducted and analyzed to identify key miRNAs with the potential
to promote the function of peripheral nerve-related cells.
2. Materials and methods
2.1. hADMSCs culture and differentiation
Primary hADMSCs (Lonza, USA) before passage 6 were cultured in
Dulbecco’s Modified Eagle’s Medium/F12 (DMEM/F12, HyClone, USA)
with 10% fetal bovine serum (FBS, Gibco, USA) and 1% penicillin/
streptomycin (P/S, Invitrogen, USA) at 37 ◦ C and 5% CO2. Differentia
tion of hADMSCs into an SC phenotype (hADMSC-SCs) could be ach
ieved using a previously published method with some modifications [13,
49–52]. Briefly, the hADMSCs were seeded on a T-175 flask at a density
of 1 × 105 cells. Differentiation was initiated in hADMSC cultures with
fresh medium containing 1 mM β-mercaptoethanol (Sigma) for 24 h.
After washing with sterilized PBS, the medium was replaced with
DMEM/F12 with 10% FBS, 1% P/S, and 35 ng/mL all-trans retinoic acid
and cells were cultured at 37 ◦ C and 5% CO2 for 72 h. After extensively
rinsing with sterilized PBS, the culture medium was replaced with fresh
medium containing 5.7 μg/mL forskolin (AdipoGen Life Sicences), 10
ng/mL basic fibroblast growth factor (bFGF, PeproTech), 200 ng/mL
recombinant hereglulin-β1 (PeproTech), 10 ng/mL brain derived neu
rotrophic factor (BDNF, PeproTech), and 5 ng/mL platelet derived
growth factor AA (PDGF-AA, PeproTech). The cells were maintained in
this medium for 14 days with medium changes every 3 days to establish
differentiated cultures.
2.2. Immunofluorescence (IF) staining
The cultured cells (hADMSCs and hADMSC-SCs) were washed three
times in PBS and fixed in 4% paraformaldehyde (PFA) at 4 ◦ C for 4 h,
respectively. Then, the samples were washed three times in PBS and
permeabilized by using 0.2% Triton X-100 (Sigma) for 10 min at room
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temperature (RT). Subsequently, the samples were blocked in 1% BSA at
4 ◦ C overnight after three PBS washes. For the evaluation of SC-like
phenotype differentiation, the samples were then incubated at 4 ◦ C
overnight with primary SC-specific antibodies, anti-S100B (1: 200,
Sigma) and anti-myelin basic protein (MBP, 1: 200, Sigma). Descriptions
related to IF staining for the evaluation of exosome uptake and hiPSC
differentiation can be found in the later sections. After washing three
times with PBS, samples were incubated with secondary fluorescent
antibodies at RT for 2 h and further incubated with DRAQ5 (1: 1000,
Thermo Scientific) for 30 min at RT. Finally, the stained samples were
washed one time in PBS and imaged with a confocal laser scanning
microscopy (CLSM, LSM710, Carl Zeriss, Germany).

ultracentrifugation for 2 h at 4 ◦ C and 100,000×g. Pellets were resus
pended in 200 μL of PBS [45,55,56]. For tracking exosome distribution
in the cells, PKH26-labeled exosomes (3 × 109/mL) were added into the
culture medium and incubated with the recipient cells (HUVECs, SCs
and macrophages) at 37 ◦ C overnight. After washing with sterilized PBS,
the cells were fixed in 4% PFA at 4 ◦ C for 4 h and permeabilized by using
0.2% Triton X-100 at RT for 10 min. Subsequently, HUVECs and rSCs
were stained by F-actin (green) and DRAQ5 (blue). macrophages were
stained by F-actin (green) and DAPI (blue). Finally, the labeled cells
were imaged using a CLSM.
2.7. rSC culture and proliferation assay

2.3. Human growth factor antibody array analysis

The rSCs were harvested from the sciatic nerves of rats according to
the protocol from our previous study [21,57]. The rSCs were then seeded
onto a poly-D-Lysine coated T-25 flask and cultured with DMEM medium
with 10% FBS and 1% P/S in 5% CO2 at 37 ◦ C. For rSC proliferation, the
rSCs (2 × 103 cells per well) were seeded in a 96 well plate and then
cultured using fresh culture medium with uExo or dExo (3 × 109/mL).
The culture medium was completely refreshed with exosome containing
medium (3 × 109/mL) every 2 days. After 1, 3, and 7 days, the prolif
eration of the rSCs was determined by a CCK8 kit assay. The culture
medium was discarded, and the cells were washed with sterilized PBS.
About 100 μL of culture medium containing 10 μL CCK8 solution
(Abcam) were added to each well, followed by incubation for 4 h at 37
◦
C. The optical density (OD) of the sample was evaluated using a
microplate reader (BioTek Synergy H1 model) at a wavelength of 460
nm. All experiments were performed in quintuplicate.

A human growth factor antibody array was used to evaluate and
compare various cytokines secreted by the hADMSCs with and without
differentiation. After 2-week culture, all of the media from the two
cellular groups was collected and analyzed by utilizing a human growth
factor array kit (RayBio C-Series), according to the manufacturer’s
protocols. This kit could detect 41 different types of human growth
factors. The arrays in each group were scanned, and signal intensities
were quantified by Image J software.
2.4. Exosome isolation and characterization
Exosomes were isolated from hADMSC (uExo) and hADMSC-SCs
(dExo) by using ultracentrifugation. Prior to exosome collection,
hADMSCs (passage 3–6) were cultured in medium with 10% exosome
depleted FBS (Gibco) and 1% P/S at 37 ◦ C and 5% CO2. The medium was
collected and centrifuged at 4 ◦ C and 300×g for 5 min, 1000×g for 20
min, and then at 10,000×g for 30 min, sequentially. Upon removing
nonadherent cells and debris, the supernatant was then filtered with a
0.22 μm filter and ultracentrifuged (Sorval X+80 Ultracentrifuge,
Thermo Fisher) at 4 ◦ C and 100,000×g for 70 min. Then the exosome
pellet was washed with PBS and centrifuged at 4 ◦ C and 100,000×g for
70 min. The collected exosomes were reconstituted in PBS and then
preserved at − 80 ◦ C. The sizes and concentrations of the final exosomes
were examined by nanoparticle tracking analysis (NTA) using a Nano
Sight (NS300) measurement. The exosome morphology was measured,
as previously described, by transmission electron microscopy (TEM,
Hitachi H7500; Hitachi) and atomic force microscopy (AFM, Bruker)
[53].

2.8. Intracellular reactive oxygen species (ROS) detection
The intracellular ROS were tested using a 2’,7′ -dichlorodihydro
fluorescein diacetate (H2DCFDA) assay (EMD Millipore). The rSCs were
seeded in 96-well culture plates with 1 × 104 cells in each well and
incubated for 24 h. Subsequently, the cells were incubated with exo
somes (uExo or dExo, 3 × 109/mL) overnight and then treated with
H2O2 (200 μM) in the present of exosomes (3 × 109/mL). After incu
bation at 37 ◦ C for 24 h, the cells were washed with PBS three times and
treated with 10 μM H2DCFDA for 20 min in the dark at 37 ◦ C. Then, the
cells were washed with PBS three times. The intracellular ROS concen
tration was measured by detecting the dihydrodichlorofluorescein
(DCF) fluorescence intensity (Ex488/Em525) through a microplate
reader. The cells that were untreated by exosomes or H2O2 were used as
a negative control. For imaging, cells were washed with PBS, fixed with
4% (w/v) PFA, and stained with DRAQ5. The cells were imaged using a
CLSM.

2.5. Western blot
The surface markers (CD9, CD63, TSG101, and Alix) of the isolated
exosomes were correspondingly detected by Western blotting as re
ported previously [53,54]. The exosomes were lysed using a Mammalian
Cell Lysis kit (Sigma) and quantified by a Micro BCA Protein Assay kit
(Pierce). Equal amounts of the proteins were electrophoresed in a so
dium dodecyl sulphate-polyacrylamide gel (10%–12%) under reducing
conditions followed by transfer to polyvinylidene fluoride (PDVF)
membranes. The blots were blocked with 5% non-fat dry milk in PBS.
Western blots were then probed with antibodies recognizing the CD9
antibody (1:1000, Abcam), CD63 antibody (1:1000, Abcam), TSG101
(1:1000, Abcam), and calnexin (1:1000, Sigma). The secondary anti
bodies were alkaline phosphatase conjugated to goat anti-mouse (Santa
Cruz)/rabbit lgG (1:5000, Jackson ImmunoResearch Labs)). Signals
were detected by chemiluminescence and imaged on an FLA-5100
(Fujifilm) digital image scanner.

2.9. HUVEC migration assay
HUVECs (Lonza) were seeded in a T-75 flask coated by collagen
(RatCol®) and cultured in endothelial cell basal medium-2 (EGM-2
BulletKit, Lonza) at 37 ◦ C and 5% CO2. The medium was replaced every
2 days. For the migration assay, HUVECs were seeded in coated 24-well
plates. Upon complete confluency, wounds were made with a 200 μL
sterile pipette tip. The detached cells were washed with PBS buffer and
then cultured in the complete medium containing exosomes (uExo or
dExo, 3 × 109/mL). The images of the scratch at different time points
were taken under an inverted microscope (Leica). The migration rate
was calculated and reported as the wound closure rate (%) according to
the formula: wound closure rate (%) = [(wound length at 0 h – wound
length at 24 h)/wound length at 0 h] × 100 [58]. At least 5 images were
randomly taken for each well and then analyzed using Image J software.
Each sample was performed in quintuplicate.

2.6. Exosome labeling and uptake in cells
Exosomes were labeled with PKH26 dye (Sigma, USA) according to
the manufacturer’s protocols for 5 min and then washed with PBS using
63
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2.10. HUVEC tube formation assay

hiPSC-SNs and SN neurospheres were evaluated using our previously
reported protocol of IF staining method [65]. The hiPSC-SNs and SN
neurosphere sections were permeabilized and blocked with 0.2% Triton
X-100 and 1% BSA in PBS overnight at 4 ◦ C, followed by incubation with
primary antibodies overnight at 4 ◦ C respectively. In detail, the
hiPSC-SNs and SN neurosphere sections were double stained with β-3
tubulin (1:200, Millipore), TRPV1 (1:200, Milliporem). After sequential
incubation with secondary antibodies for 2 h and DRAQ5 (1:400,
Thermo Scientific) for 30 min at RT, stained samples were imaged using
a CLSM. For tracking exosome distribution in the hiPSC-SNs,
PKH26-labeled exosomes (uExo and dExo) were added into the culture
medium incubated with the recipient cells at 37 ◦ C for 12 h. After IF
staining, the labeled cells were imaged using a CLSM.

The tube formation assay was performed using a method similar to
our previously reported one [58]. Briefly, 50 μL of cold Matrigel
(Corning) were added into each well in a 96-well plate and cultured at
37 ◦ C for 1 h. After the Matrigel coating was applied, HUVECs were
seeded onto the Matrigel-coated wells with 100 μL medium at a density
of 1 × 105 cells/mL and then cultured in presence of exosomes (uExo or
dExo, 3 × 109/mL) for 16 h at 37 ◦ C. Tube images (n = 5) were randomly
taken under an inverted microscope. The observed total tube node
branch points in each image were counted using ImageJ software.
2.11. Monocyte differentiation and anti-inflammatory activity evaluation

2.13. Calculation of average axon length of hiPSC-SN neurospheres

Monocytes isolated from peripheral blood mononuclear cells from
anonymous human blood samples and were provided by the Elutriation
Core Facility at the University of Nebraska Medical Center. Differenti
ation of monocytes into Mɸ and M1 macrophage was performed
following a protocol modified from previous studies [59,60]. Briefly, 5
× 105 monocytes were seeded on sterile glass coverslips in 24-well plates
and then cultured for 6 days in RPMI 1640 medium (Gibco) containing
10% FBS, 1% P/S, and 50 ng/mL of recombinant granulocyte macro
phage colony-stimulating factor (GM-CSF, PeproTech). After 6 days, the
cell culture medium was changed with fresh medium containing uExo or
dExo (3 × 109/mL) and GM-CSF and cultured overnight. Then, Mɸ
macrophages were stimulated with 100 ng/mL lipopolysaccharide (LPS)
and 20 ng/mL interferon-gamma (IFN-γ) in the present of exosomes (3
× 109/mL). The experiment was divided into four groups: the negative
control group (without stimulation and without exosomes), the positive
control LPS group (with LPS/IFNγ stimulation), and treated groups
(LPS/IFNγ + uExo, LPS/IFNγ + dExo). After overnight incubation, the
culture medium was collected to assay the cytokines’ levels of IL-1β,
IL-6, and TNF-α with ELISA kits (bio-techne®) according to manufac
turer’s instructions. Real-time polymerase chain reaction (RT-PCR) was
also conducted to evaluate the gene expressions of nuclear factor kappa
B (NFκB), tumor necrosis factor (TNF), and nitric oxide synthase 2
(NOS2), as described in the later section. All the test results were per
formed in quadruplicate.

After culture in Matrigel for 24 h, the SN neurospheres were then
treated with exosomes (uExo or dExo) at 3 × 109/mL and cultured for 6
days. The culture medium was completely refreshed with exosome
containing medium (3 × 109/mL) every 2 days. The SN neurospheres
without treatment with exosomes were employed as the control group.
The images of SN neurospheres were captured using an inverted mi
croscope on days 0, 2, 4, and 6. Three parallel samples per group were
performed, and three images were captured for each sample. The
average length of the longest 10 axons of each image was measured
using Image J. Thirty measurements for each sample were chosen to
calculate the average length of longest axon.
2.14. Quantitative RT-PCR analysis
The total RNA from the cells (macrophages or hiPSCs) was analyzed
by RT-PCR. Briefly, the total RNA was isolated from cells using QIAshredder and RNeasy mini-kits (QIAGEN). Complementary DNA
(cDNA) was synthesized by following the protocol of an iScript cDNA
synthesis kit (BioRad Laboratories). For the quantitative analysis of the
total RNA expression, real-time PCR amplification was performed in a
StepOnePlus™ Real-Time PCR System (Thermo Scientific) with the use
of SYBR Green Supermix (Bio-Rad). The cDNA samples were analyzed
for the genes of interest and for the housekeeping gene 18S rRNA. The
relative expression of each target gene (as shown in Table S1) was
calculated using the comparative Ct (2− ΔΔCt) method [58].

2.12. hiPSC differentiation into SNs and neurosphere formation
The differentiation of hiPSCs into SNs (hiPSC-SNs) was conducted
following a modified protocol [61–64]. Briefly, hiPSCs (WiCell®) were
originally cultured in mTesR medium (STEMCELL™). Then, hiPSCs
were cultured on a Matrigel coated 6-well plate at a seeding density of 3
× 105 cells/well. As shown in Fig. 6A, the neural differentiation of iPSCs
(day 0–2) was initiated using KSR medium (Gibco) containing β-mer
captoethanol and two inhibitors (100 nM LDN1931189 and 10 μM
SB431542) at 37 ◦ C. Cells were fed daily, and N2 minus VA medium was
added in increasing 25% increments every other day starting on day 4.
N2 medium was Neurobasal medium (1X, Gibco) with 0.1% v/v P/S, 2%
v/v B27 (50X, Gibco), 1% v/v GlutaMAX (100X, Gibco), and 1% v/v
non-Essential Amino Acids (100X, NEAA, ScienCell). The induction of
SNs was initiated with addition of the five inhibitors on days 2–6,
including 100 nM LDN1931189, 10 μM SB431542, 3 μM CHIR99021
(Millipore), 10 μM SU5402, and 10 μM DAPT (Millipore). On days 6–10,
the induction of SNs was initiated with addition of the three inhibitors,
including 3 μM CHIR99021, 10 μM SU5402, and 10 μM DAPT. On day
10, hiPSC-SNs were dissociated with Accutase (Gibco) and seeded at a
density of 2 × 105 cells/well in 150 μL of medium in a 96-well
non-adherent U bottom plate (Corning) for neurosphere formation.
The SN neurospheres were allowed to grow in maintain medium (neu
robasal medium, 1% v/v P/S, 25 ng/mL human-b-NGF, BDNF, and glial
cell line derived neurotrophic factor (GDNF)) for one week. The neu
rospheres were then embedded in Matrigel and transferred into a 6-well
plate and cultured in neural differentiation medium for 24 h.

2.15. miRNA sequencing analysis
The total RNAs were isolated from hADMSC and differentiated
hADMSCs using RNeasy mini kits (QIAGEN) according to the manu
facturer’s instructions. For exosomes (uExo and dExo), the total RNAs
were extracted using a Total exosome RNA isolation kit (Thermo Sci
entific), following the manufacturer’s protocol. The miRNA sequencing
analysis was conducted by LC Sciences (Houston, TX, USA). The total
RNA quality and quantity were analysis of Bioanalyzer 2100 (Agilent)
with RIN number >7.0. Approximately 1 μg of total RNA were used to
prepare small RNA library according to protocol of TruSeq Small RNA
Sample Prep Kits (Illumina). The single-end sequencing 50 bp on an
Illumina Hiseq 2500 at the LC Sciences following the vendor’s recom
mended protocol. For bioinformatics analysis, the raw reads were sub
jected to an in-house program, ACGT101-miR (LC Sciences) to remove
adapter dimers, junk, low complexity, common RNA families (rRNA,
tRNA, snRNA, snoRNA) and repeats. Subsequently, unique sequences
with length in 18–26 nucleotide were mapped to specific species pre
cursors in miRBase 22.0 by BLAST search to identify known miRNAs and
novel 3p- and 5p- derived miRNAs. Length variation at both 3′ and 5′
ends and one mismatch inside of the sequence were allowed in the
alignment. The unique sequences mapping to specific species mature
miRNAs in hairpin arms were identified as known miRNAs. The unique
sequences mapping to the other arm of known specific species precursor
64
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hairpin opposite to the annotated mature miRNA-containing arm were
considered to be novel 5p- or 3p derived miRNA candidates. To predict
the genes targeted by most abundant miRNAs, two computational target
prediction algorithms TargetScan and Miranda 3.3a were used to iden
tify miRNA binding sites. The kyoto encyclopedia of genes and genomes
(KEGG) pathways of these most abundant miRNAs, miRNA targets were
annotated. The volcano plots were generated from log2(fold change)
values of all miRNAs by a home-made R script. The heatmaps were
plotted by R packages, pheatmap (v1.0.12), ggplot2 (v3.3.3) and gplots
(v3.1.1), based on the values of log2(normalized_expression_value +
0.0001) in each sample to avoid any nonsense values of log2(0). The R
4.0.3 was used for both volcano and heatmap generation. The pathways
for miRNA-132-3p and miRNA-199b-5p were predicted using the data
base miRPathDB 2.0 [66]. The networks were constructed using Cyto
scape 3.8.2 using the miRNA and their interacting pathways [67].

2.16. Statistical analysis
All experiments were repeated at least thrice. Results are expressed
as the mean ± standard deviation (SD). Statistical analysis was per
formed by GraphPad Prism using one-way analysis of variance
(ANOVA). Differences were considered to be significant when *p < 0.05.
3. Results
3.1. Characterization and comparison of hADMSCs with and without
differentiation into the SC-phenotype
hADMSCs were differentiated into the SC-like phenotype following
our previous protocol with some modification (Fig. 1A) [21]. The
morphologies and biomarkers of undifferentiated and differentiated
hADMSCs were evaluated after 2-week differentiation. It was clear from
optical microscopy that hADMSCs maintained a flattened fibroblast-like

Fig. 1. Characterization and comparison of hADMSCs with and without differentiation into SCs. (A) Schematic of the differentiation protocol of hADMSCs into SClike cells. (B) Optical microscope and IF images of hADMSCs and hADMSC-SCs. (Optical microscope image scale bar: 250 μm, IF image scale bar: 100 μm). (C)
Representative images of a human growth factor antibody array for supernatant culture media of hADMSCs and hADMSC-SCs. (D) Semi-quantitative analysis of the
secreted growth factors with statistical difference. Relative expression of each targeted growth factor was presented as normalized to the positive control on the same
array and relative to the hADMSC control group (n = 4, *p < 0.05, **p < 0.01, ***p < 0.001).
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morphology and that hADMSC-SCs showed a spindle-shaped cell
morphology (Fig. 1B), which was similar to genuine SCs. To verify the
differentiation, we stained for S100B and MBP, the markers for SCs and
myelinating SCs [68,69]. IF staining, shown in Fig. 1B, showed that
hADMSC-SCs expressed much higher levels of S100B and MBP than that
of hADMSCs, indicating successful differentiation. Moreover, to eval
uate the myelination capacity of hADMSC-SCs, a co-culture of
hADMSC-SCs and sensory neurons isolated from mouse dorsal root
ganglion (DRG) was further employed. After a 21-day co-culture,
hADMSC-SCs myelinated the axons of DRG neurons, with the expres
sion of MBP highly localized along the axon fiber (Fig. S1A). TEM im
aging also confirmed the formation of a myelin sheath (Fig. S1B). These
results indicated that hADMSCs were successfully differentiated into an
SC-like cell lineage and that hADMSC-SCs were able to myelinate
neuronal axons.
We also applied a human growth factor antibody array to evaluate
and compare the human growth factor secretome profiling of hADMSCs
with and without differentiation. As shown in Fig. 1C, the hADMSC-SCs
secreted significantly more growth factors after induction, including
bFGF, beta nerve growth factor (β-NGF), epidermal growth factorreceptor (EGFR), epidermal growth factor (EGF), neurotrophin (NT)3,4, GDNF, hepatocyte growth factor (HGF), transforming growth factor
(TGF) β, and vascular endothelial growth factor (VEGF) A and D. Most of
these growth factors are neurotrophic factors that can support the
growth and differentiation of both developing and mature neurons and
protect neurons under pathological conditions [70]. Many of the growth
factors mentioned above are also responsible for regulating angiogenesis
and inflammation during peripheral nerve repair and regeneration [63].
Meanwhile, several other growth factors, like granulocyte colony stim
ulating factor (GCSF) and insulin-like growth factor 1 receptor (IGF-1R),
were also highly secreted from hADMSC-SCs after induction. These
factors are well-known to regulate the proliferation, differentiation, and
activation of neutrophilic granulocyte lineage cells [71,72]. Interest
ingly, only the secretion of TGFα was decreased from hADMSC-SCs
compared to hADMSCs. The reason and mechanism are still unclear.
We speculate that this might be related to intrinsic cellular secretion
properties [73,74].

3.2. Isolation and characterization of exosomes from hADMSC and
hADMSC-SC media
In this study, the cell culture media of both hADMSCs and hADMSCSCs were collected, and the exosomes were further isolated by using
ultracentrifugation following the protocols shown in Fig. 2A. The su
pernatant media went through serial ultracentrifugation, and the exo
some pellets were reconstituted in PBS and stored at − 80 ◦ C before use.
Then, we characterized the exosomes by using NTA, AFM, TEM, and
western blotting. Herein, exosomes isolated from hADMSCs with and
without differentiation are abbreviated as dExo and uExo, respectively.
The results shown in Fig. 2B showed that the average sizes of uExo
and dExo were 144 ± 45 nm and 165 ± 48 nm, while the average
concentrations of uExo and dExo were (5.62 ± 0.39) × 109/mL and
(7.99 ± 0.42) × 109/mL, respectively. NTA analysis indicated that the
size distribution of both uExo and dExo ranged mainly from 99 to 213
nm. The AFM images showed that the particle pellets were round-shaped
vesicles in nanoscale (Fig. 1C). The TEM images showed more detailed
morphologies of uExo and dExo, demonstrating that the particle pellets
were cup-like vesicles with bounded membranes (Fig. 1D). Both AFM
and TEM images also suggested that both uExo and dExo were nano
sized. In our study, western blot analysis demonstrated that both uExo
and dExo, after final ultracentrifugation at 100,000 × g, positively
expressed CD9, CD63, TSG101 and Alix, which are well-known exosome
biomarkers [33,34] (Fig. 2E). We also collected the supernatants during
the intermediate centrifugation steps for the western blot. Compared to
the final pellet under ultracentrifugation of 100,000 × g, we could not
significantly detect these exosome biomarkers (except for TSG101) in
the dead cells and debris under centrifugation of 1000 × g or 10,000 × g
(Fig. 2E). The detected TSG101 might belong to the few EVs with large
sizes that were deposited during 10,000 × g centrifugation. In contrast,
Calnexin, a negative biomarker for exosomes, was undetectable in both
uExo and dExo but found in the cell lysate (under centrifugal rate of 10,
000 × g), verifying the purity of the exosomes. Altogether, these results
implied that uExo and dExo were successfully isolated with comparable
particle sizes, morphologies, purities, and biomarkers.

Fig. 2. Characterizations of exosomes derived from hADMSCs and hADMSC-SCs. (A) Schematic of the protocol for exosome isolation from cell culture media. (B) Size
distribution of uExo and dExo was obtained from NTA test, inset showing representative exosome images captured from the NTA video frames. (C) AFM images of
uExo and dExo (scale bar 250 nm). (D) TEM images of uExo and dExo (scale bar 100 nm). (E) Proteins from each centrifugal rate (1k × g : 1000 × g, 10k × g:10,000 ×
g, and 100k × g: 100,000 × g) were analyzed by western blot for the presence of exosome-associated proteins CD9, CD63, TSG101, and Alix.
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3.3. Effects of exosomes isolated from hADMSC with and without
differentiation on the anti-oxidation and proliferation for rSCs

Meanwhile, compared to the control group, uExo only significantly
increased rSC proliferation at days 1 and 3 (Fig. 3D), indicating that the
effect of uExo on proliferation might be transient. These results suggest
that both uExo and dExo protected rSCs from oxidative stress and dExo
had more effects on improving rSC proliferation.

Herein, rSCs were used as a model cell type in vitro to evaluate the
functional anti-oxidation and proliferation of exosomes. To determine
whether exosomes could be captured by rSCs and what the distribution
of exosomes was, both uExo and dExo were labeled by PKH26 and then
co-cultured with rSCs. As shown in Fig. 3A, significant amounts of
PKH26 labeled exosomes were found to be taken up by rSCs after a 12 h
co-culture.
To find out whether the exosomes could protect the rSCs from H2O2induced oxidative stress, we used H2DCFDA, a hydrogen peroxide
(H2O2)-specific probe, to evaluate ROS produced by rSCs [75]. We first
optimized the H2O2 dose to maximize the oxidative stress while mini
mizing the effects on rSC viability (Fig. S2). Based on Live/Dead and
CCK-8 assay results, the concentration of H2O2 was selected to be 200
μM. To the best of our knowledge, the concentrations of exosomes
ranging from 109 to 1012/mL are applied for system administration in
vivo [55,76–78]. Thus, in order to ensure that the amount of exosomes
derived from hADMSCs was sufficient, the concentration of exosomes
was chosen to be 3 × 109/mL. rSCs co-incubated with H2O2 and exo
somes (either uExo or dExo) showed significantly lower green fluores
cence than the control group (200 μM H2O2 treatment only), suggesting
that both uExo and dExo could effectively attenuate the intracellular
oxidative stress (Fig. 3B). The H2O2 treatment significantly increased the
oxidation of rSCs (Fig. 3C). The green fluorescence intensity of rSCs was
further quantitatively confirmed to be significantly lower after the
incorporation of exosomes (Fig. 3C). These results are consistent with
previous reports that exosome derived from MSCs effectively mitigated
oxidation [79]. However, there was no significant difference between
the groups with uExo and dExo. The proliferation of rSCs was examined
via a CCK-8 assay. As shown in Fig. 3D, the absorbance intensity of rSCs
co-cultured with dExo was higher than the control group at days 1, 3,
and 7, demonstrating that the dExo could promote rSCs proliferation.
We could also observe that the average of absorbance intensity of rSCs
treated with dExo was significantly higher at day 1 than that of rSCs
treated with uExo, but such a trend was not detected at days 3 or 7.

3.4. Effects of exosomes from hADMSCs with and without differentiation
on angiogenesis of HUVECs
It has been reported that exosomes derived from MSCs could pro
mote angiogenesis [80,81]. In this study, tube formation and migration
assays were used to investigate the angiogenesis of HUVECs after
treatment with uExo and dExo. We first examined the distribution of
exosomes in the HUVECs. As shown in Fig. 4A, significant amounts of
PKH26 labeled exosomes (both uExo and dExo) were captured by
HUVECs compared to rSCs and other cell types, as shown previously or
later in this study. This indicates that endothelial cells may be more
intent to uptake and internalize exosomes in vitro.
Subsequently, we seeded HUVECs onto Matrigel in the presence of
uExo or dExo, and a vascular tubular structure was developed. As shown
in Fig. 4B, the node density for HUVECs was significantly increased after
incubation in the presence of uExo and dExo, compared to the normal
medium alone. Moreover, the number of branches was quantified. It was
found that the average number of branches for HUVECs treated by dExo
(86 nodes) was higher than those incubated with PBS (73 nodes) or uExo
(80 nodes) (Fig. 4D). The results indicated that dExo significantly
enhanced the angiogenic activity of endothelial cells. We further eval
uated how exosomes affected HUVEC migration by using a scratch
wound healing assay. The scratch site was first created on the confluent
monolayer of HUVECs by the mechanical removal of a portion of cells
using a pipette tip. Then the HUVECs started migrating to heal the
scratch site (Fig. 4C). After 24 h migration, we found that HUVECs
treated with dExo showed the highest wound closure ratio, which was
significantly higher than the treatment with PBS alone (Fig. 4C and E).
All these data suggested that dExo released from hADMSC-SCs played
positive roles in angiogenesis of HUVECs.

Fig. 3. Exosome uptake and their effects on anti-oxidation and proliferation of rSCs. (A) Exosomes labeled with PKH26 were incubated with rSCs for 12 h, and the
exosome uptake by rSCs was revealed under CLSM. Scale bar, 100 μm. (B) The mitigation of oxidative stress in rSCs was monitored via H2DCFDA staining after
different treatments with H2O2, H2O2 +uExo, or H2O2 +dExo. Scale bar, 100 μm. (C) Oxidized H2DCFDA fluorescence signal intensity was quantified by a microplate
reader (Ex = 488 nm, Em = 535 nm) (n = 5). (D) CCK-8 assay to detect rSC proliferation (n = 5). *p < 0.05, **p < 0.01, ***p < 0.001, ns: no significant difference.
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Fig. 4. Effects of uExo and dExo on HUVEC angiogenesis in vitro. (A) Exosomes labeled with PKH26 were incubated with HUVECs for 12 h, and the exosomes
captured by HUVECs were revealed under CLSM. Scale bar, 100 μm. (B) Optical microscope images showed the tube formation with and without co-cultures with
uExo or dExo. Scale bar, 500 μm. (C) Bright-field microscope images showed the migration of HUVECs after treatment with uExo or dExo. Scale bar, 500 μm. (D)
Semi-quantitative measurement of the number of branch points per field in tube formation (n = 5). (E) Semi-quantitative measurement of the distance of cell
migration in the wound scratch assay (n = 5). *p < 0.05, **p < 0.01, ns: no significant difference.

Fig. 5. The anti-inflammatory effects of uExo and dExo on human monocyte derived M1 macrophages. (A) Schematic of the protocol of monocyte differentiation into
macrophages and M1 macrophages. (B) Exosomes labeled with PKH26 were incubated with macrophages for 12 h, and the exosome uptake by macrophages was
revealed under CLSM. Scale bar, 5 μm. (C) The relative gene expressions of NFκB, TNF, and NOS2 in M1 macrophages after the indicated treatments. (n = 4). (D)
Cytokine secretions of TNF-α, IL-1β, and IL-6 from the supernatants by M1 macrophages were detected by ELISA (n = 4). *p < 0.05, **p < 0.01, ***p < 0.001, ****p
< 0.0001, ns: no significant difference.
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3.5. Anti-inflammatory effects of uExo and dExo on M1 macrophages

significantly upregulated in M1 macrophages after activation and
significantly downregulated in the groups treated with exosomes
(Fig. 5C). The addition of dExo statistically downregulated NFκB and
TNF expressions compared to the counterparts with uExo treatment
(Fig. 5C). We further measured the M1 macrophage secreted inflam
matory cytokines, as shown in Fig. 5D. As expected, the secretion levels
of TNF-α, interleukin (IL)-1β, and IL-6 were significantly increased after
stimulation with LPS/IFN-γ. After treatment with uExo or dExo, the proinflammatory cytokine secretions were significantly decreased, espe
cially for the groups with the addition of dExo (Fig. 5D). These results
demonstrate that both uExo and dExo have anti-inflammatory effects by
downregulating pro-inflammatory gene expressions and cytokine se
cretions. Moreover, dExo showed an improved outcome in modulating
the anti-inflammatory activity for monocyte derived M1 macrophages.

Next, we used human monocyte to differentiate into proinflammatory M1 macrophages, aiming at exploring how these im
mune cells respond to uExo and dExo. As shown in Fig. 5A, monocytes
were treated with GM-CSF to facilitate their attachment and differenti
ation into macrophages (Mɸ) [82]. Both uExo and dExo were labeled by
PKH26 and were captured by the macrophages after 12 h co-cultures
(Fig. 5B).
To explore the anti-inflammatory effects of uExo and dExo on M1
macrophages, the macrophages were co-cultured with exosomes and
then stimulated to the M1 phenotype using LPS/IFN-γ. We quantita
tively detected several gene expressions related to pro-inflammation,
including nuclear factor kappa B (NFκB), tumor necrosis factor (TNF),
and nitric oxide synthase 2 (NOS2), by RT-PCR (primers shown in
Table S1). The relative expressions of these three genes were

Fig. 6. Effects of uExo and dExo on the growth of SNs derived from hiPSCs. (A) Schematic of the differentiation protocol of hiPSCs into SNs and further hiPSC-SN
neurospheres. (B) Expression levels of ISL1, PRPH, BRN3A, OCT4, NTRK1, SCN9A, SCN10A, SCN11A, P2RX3, and TRPV1 for SNs were evaluated by RT-PCR. (n = 3).
(C) IF staining images of hiPSC-SNs. hiPSC-SNs were positive for β-3 tubulin, TRPV1, and DRAQ5. Scale bar 50 μm. (D) IF staining images of hiPSC-SN neurospheres
with β-3 tubulin, TRPV1, and DAPI. Scale bar 100 μm. (E) Representative IF images of axons from neurospheres after being encapsulated within Matrigel and treated
with PBS, uExo, or dExo. Scale bar 500 μm. (F) Representative optical microscopic images of encapsulated neurospheres treated with PBS, uExo, or dExo for 6 days.
Scale bar 500 μm (G) Semi-quantitative analysis of axon length of encapsulated neurospheres after treatment with uExo or dExo for 0, 2, 4, and 6 days (n = 3). *p <
0.05, **p < 0.01, ***p < 0.001.
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hiPSC. The hiPSCs were first differentiated into SN-like cells using a
previously reported method with some modifications (Fig. 6A) [83], and
then the hiPSC-SNs were cultured and induced into neurospheres for
further encapsulation and characterization with exosomes.
After 10-day induction, the gene expressions of insulin gene
enhancer protein (ISL1), peripherin (PRPH), and brain-specific

3.6. Effects of exosomes on the growth of axons of hiPSC derived
peripheral SNs
Since axon growth and reconnection are of the most importance
during peripheral nerve repair and regeneration, we further investigated
the effect of dExo and uExo on the growth of SNs differentiated from

Fig. 7. miRNA sequencing analysis. (A) Heatmap and hierarchical clustering depicting the normalized Z-scaled expression of miRNA in the four groups (n = 3 for
each group). (B) The Venn diagram of all differentially expressed miRNAs identified in the four groups. (C) Heatmap of significant differential expression of miRNAs
in uExo and dExo groups (n = 3, <p<0.05). (D) Volcano plot showing differences in exosomal miRNAs expressed in the uExo and dExo groups. Note for spot colors:
black, insignificant; red, <p≤0.05; orange, log2FoldChange ≥1 or ≤ -1; green, both red and orange criteria fulfilled. (E) The top 20 common KEGG pathways of the
differentially expressed miRNAs in the uExo and dExo groups. Number of target genes enriched in KEGG pathway, p value and rich factor are shown in scatterplot.
Rich factor = (number of target genes in KEGG pathway)/(total number of genes in KEGG pathway). The networks predicted by the miRPathDB database for the
upregulated miRNAs (miRNA-132-3p (F) and miRNA-199b-5p (G)), showing the associated functional signaling pathways. The circle size (larger to smaller) rep
resents the number of hits or genes in the interacting pathway.
70

B. Liu et al.

Bioactive Materials 14 (2022) 61–75

than that for uExo, while hADMSC-SCs contained less miRNAs than
hADMSCs. Other studies also reported similar results, that the miRNAs
in exosomes did not merely reflect the cellular content, and some
distinct miRNAs were overrepresented in exosomes compared to the cell
of origin [89]. We further focused more on the differential expression of
miRNAs between uExo and dExo groups. The heatmap and volcano plot,
as shown in Fig. 7C and D, displayed the differentially expressed miR
NAs. The results revealed a greater number of miRNAs with a statisti
cally significant alteration in expression in the uExo and dExo groups.
KEGG pathway enrichment analysis was used to identify the significant
biological pathways related to the differentially expressed miRNAs. In
this study, the top 20 signaling pathways were predicted (Fig. 7E).
Significantly enriched KEGG categories included the thyroid hormone
signaling pathway, Ras signaling pathway, MAPK signaling pathway,
Oxytocin signaling pathway, inflammatory mediator regulation of TRP
channels, etc. Among various differentially expressed miRNAs,
miRNA-132-3p (p = 1.16E-04, log 2 (fold change) = 1.54) and
miRNA-199b-5p (p = 3.28E-02, log 2 (fold change) = 1.65) have caught
our attention because both of them had high reads (>5000) in all the
four groups and were significantly upregulated in the dExo group. The
pathway annotations of both miRNA-132-3p and miRNA-199b-5p were
predicted by miRPathDB database based on KEGG and shown in Fig. 7F
and G. Each pathway is filtered based on the significant P-value < 0.05
and their expected hits, predicted hits and predicted evidence were
provided in the supplementary file (Table S2 and Table S3). As shown in
Fig. 7F, miRNA-132-3p is related to many targets and physiological
signaling pathways. In this study, we are particularly interested in some
of the targets associated with neural or axonal growth, such as the
neurotrophin signaling pathway, axon guidance, VEGF signaling
pathway, and TGF-β signaling pathway. miRNA-199b-5p is also associ
ated with some special signaling pathways related to peripheral nerve
repair, such as TNF signaling pathway, mTOR signaling pathway, notch
signaling pathway. Both the MAPK signaling pathway and axon guid
ance are associated with miRNA-132-3p and miRNA-199b-5p.

homeobox/POU domain protein 3A (BRN3A), which are biomarkers of
sensory and peripheral neurons, were significantly enhanced compared
to hiPSCs. Meanwhile, octamer-binding transcription factor 4 (OCT4)
expression, the marker of undifferentiated pluripotent stem cells, was
downregulated for hiPSC-SNs. Moreover, the gene expressions of several
receptors, like neurotrophic tyrosine kinase receptor type 1 (NTRK1),
P2X purinoceptor 3 (P2RX3), and transient receptor potential cation
channel subfamily V member 1 (TRPV1), were also upregulated after
induction. These receptors are biomarkers for nociceptors that are
highly related to peripheral pain responses. The expressions of sodium
voltage-gated channel alpha subunit 9 (SCN9A), SCN10A, and SCN11A
for hiPSC-SNs were also greatly upregulated. These genes are related to
sodium channels with the function of transmitting pain signals. The
expressions of all these genes indicate that some of these cells were
differentiated into nociceptive neurons [83,84]. IF staining further
confirmed the positive expressions of β-3 tubulin and TRPV1, which
exist in sensory neurons, in the hiPSC-SNs after induction (Fig. 6C). Then
hiPSC-SNs were passaged and replated in a non-adhesive plate to obtain
hiPSC-SN neurospheres. As shown in Fig. 6D, SN neurospheres were
successfully formed after 7-day culture, and the obtained SN neuro
spheres strongly expressed the markers of β-3 tubulin and TRPV1. We
further encapsulated hiPSC-SN neurospheres within Matrigel. Figs. S3
and S4 showed that hiPSC-SN neurospheres grew very well within
Matrigel, with extensive axon outgrowth and positive expression of
BRN3A. To explore whether SNs were able to capture exosomes, we
isolated mouse DRG neurons and treated them with exosomes labeled
with PKH26. Different from other peripheral nerve-related cell types,
exosomes were not extensively captured by DRG neuron cell bodies in
vitro (Fig. S5). Instead, the exosomes were distributed around the axons
of DRG neurons (Fig. S5). Other studies also showed that glial cells could
absorb more MSC derived exosomes than neurons [85].
We also used PKH26 labeled exosomes to treat hiPSC-SNs. As shown
in Fig. S6, PKH26 labeled exosomes (both uExo and dExo) were also
captured by hiPSC-SNs. Comparing to mouse DRG neurons, slightly
more exosomes were internalizated into hiPSC-SNs. We further evalu
ated the effects of exosomes on axon outgrowth from hiPSC-SN neuro
spheres. The neurospheres were encapsulated within Matrigel and then
treated with PBS, uExo, or dExo. After 6-day cultures, the axon length of
the neurospheres with dExo was longer than those treated with PBS or
uExo (Fig. 6E). In addition, the area of axon outgrowth was larger for the
neurospheres with dExo treatment (Fig. 6F). Semi-quantitative analysis
showed that the neural axon length of SN spheres treated by dExo was
larger than other groups on days 2, 4, and 6 (Fig. 6G). Taken together,
these results indicated that dExo could promote neural axon growth.

4. Discussion
SCs are the main glial cells in the adult peripheral nervous system,
and they wrap around peripheral axons of motor and sensory neurons to
form the myelin sheath and are required for successful nerve regenera
tion [90,91]. ADMSCs have characteristics of mesenchymal tissue line
ages and could differentiate into SC-like phenotypes [92]. It is widely
accepted that the SC-like cells differentiated from ADMSCs have a
beneficial role for the treatment of peripheral nerve injuries [19,93].
Our previous studies have reported that aligned topography, electrical
stimulation, and neural differentiation media promoted hADMSC dif
ferentiation towards myelinating SCs [21,52]. In the present study,
hADMSC-SCs were achieved by the differentiation of hADMSCs using
previously defined induction medium plus BDNF, which has been re
ported to promote SC marker expressions and myelination [94,95]. We
have demonstrated that the differentiation process enhanced the cellular
secretory properties, showing more neurotrophic and growth factors in
the hADMSC-SC secretome. In addition, the hADMSC-SCs had myeli
nation capacity, as shown in previous studies [96,97], and formed a
myelin sheath around axons after being co-cultured with rat DRG neu
rons. Both secretion and myelination features may explain why
hADMSC-SCs had superior efficacy in treating peripheral nerve injuries.
Following the differentiation of hADMSCs, we focused on exosomes
isolation from hADMSCs with and without differentiation. Some litera
tures have reported that MSC-derived exosomes, with MSC-sourced
neuroprotective and immunomodulatory miRNAs, attenuate neuroinflammation, promote neo-vascularization, induce neurogenesis, and
reduce apoptotic loss of neural cells [55,98,99]. Therefore, exosomes, as
important mediators for intercellular and intracellular communication,
are ideal natural nanocarriers for (stem) cell free therapy due to their
biocompatible characteristics and immune-friendly nature [100–102].

3.7. miRNA sequencing analysis
Many studies have revealed the regulatory roles of miRNAs loaded
within exosomes in peripheral nerve injury [3,86] and spinal cord injury
[87,88]. Therefore, we evaluated the miRNA expression profiles in
hADMSCs, hADMSC-SCs, and their derived uExo and dExo via miRNA
sequencing and bioinformatic analysis. To visualize overall miRNA
expression differences among the four groups, an overall heatmap was
generated, including all the identified miRNAs (a total of 956 miRNAs)
(Fig. 7A). A number of commonalities in exosomal and intercellular
secretion profiles of miRNA were observed (Fig. 7A), with uExo and
hADMSC samples clustering tightly together. Interestingly, many miR
NAs were either downregulated or undetectable in the uExo group
compared to those in their parent cell group (i.e., hADMSC group), while
the miRNA contents for dExo and hADMSC-SCs revealed high similarity.
The Venn diagram showed the overlapping and nonoverlapping miRNAs
in the four groups (Fig. 7B). In detail, the number of identified miRNAs
for hADMSC-SCs and hADMSCs was 364 and 482, respectively. For the
exosomes, the number of miRNAs for dExo and uExo was 428 and 245,
respectively. Moreover, dExo contained 217 miRNAs that were not
present in uExo. Interestingly, the number of miRNAs for dExo was more
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Thus, we hypothesize that hADMSC–SC–derived exosomes possess the
functions of their parent cells, so they can regulate the peripheral
nerve-related cell behaviors under physiological and pathological con
ditions. We thus successfully isolated exosomes from hADMSCs and
hADMSC-SCs (i.e., uExo and dExo), which had nanoscale sizes and
cup-like morphologies, and we systematically studied and compared the
anti-ROS, anti-inflammatory, angiogenic, and axonal growth promoting
properties of uExo and dExo.
Peripheral nerve injuries induce remarkable ROS production and
accumulation, which in turn result in oxidative damage, neuro
inflammation, and peripheral nerve injury induced neuropathic pain
[103,104]. Many proteins/compounds with antioxidant activities have
been effectively used to treat peripheral nerve injuries [105–107]. Our
results demonstrated that both uExo and dExo had ROS-scavenging ac
tivities and significantly reduced the oxidative stress in rSCs. Several
studies have reported that MSC-derived exosomes combat oxidative
stress-induced damage through adaptive regulation of the nuclear factor
erythroid 2-related factor 2 (Nrf2) defense system [59,90,91]. Both dExo
and uExo significantly improved the ROS defense capacity compared to
control group. The dExo also promoted SC proliferation at day 1, 3 and
7. Since neurons have relatively weak antioxidant defense mechanisms,
exogenous antioxidants or antioxidants released from SCs will provide
effective neuroprotection against oxidative stress [90,108].
Immediately after peripheral nerve injury, macrophages are
recruited to the lesion to aid myelin debris elimination and tissue
remodeling [109]. However, excessive macrophage accumulation and
pro-inflammation are major obstacles for nerve repair and contribute to
the initiation and maintenance of persistent nerve injury-induced pain
[110]. MSC-derived exosomes, similar to their parent cells, have been
reported to have anti-inflammatory effects. For example, MSC-derived
exosomes attenuated brain injuries by inhibiting glial inflammation
[111,112]. Our current study was consistent with previously reports that
hADMSC exosomes reduced pro-inflammatory gene expressions and
cytokine releases from M1 macrophages. Importantly, the differentia
tion process towards the SC phenotype not only did not have negative
effects on anti-inflammatory activities but also enhanced the properties.
Angiogenesis and axon growth are two important key factors because
the lack of blood supply and slow intrinsic growth rate of axons are the
major constraints for peripheral nerve repair, especially for long-gap
defects. In this study, only dExo showed significant effects on HUVECs
in terms of tube formation and migration, indicating that angiogenesis
was enhanced. This may be slightly inconsistent with previous reports
that hADMSC-derived exosomes were shown to have the ability to
promote angiogenesis of HUVECs, which could reconstruct the micro
vasculature network of the spinal cord injury model [80,113]. The dif
ference may be due to the differences of donor cells and culture
conditions. Similarly, we only found a significant enhancement of neu
rite outgrowth and axon length in the hiPSC-SN neurosphere group
treated with dExo. Guo et al. reported that intranasal administration of
MSC derived exosomes enhanced axonal growth and neovascularization
while reducing microgliosis and astrogliosis in a rat model with a spinal
cord injury [55]. Our current study indicates that dExo might have a
better therapeutic efficacy for angiogenesis and axon outgrowth then
that of uExo. We observed that PKH26-labeled uExo and dExo had
higher internalization in HUVECs compared to other cells. We also
found that the amounts of exosomes uptake by DRG neurons an
hiPSC-SNs were lower compared to HUVECs and rat SCs. The detailed
reason and mechanism are unclear. Haertinger et al. reported that
ADMSC derived exosomes entered the SCs via endocytosis-related pro
cesses and did not bind to or fuse with the SC membrane [114]. In
another study, Pulliam et al. also reported that less exosomes were
captured by neural cells compared to astrocytes [115]. Ren et al. re
ported that exosomes could be uptake at peripheral nerve endings and
transport of DRG neurons and motor neurons in the anterior horn of the
spinal cord. It also showed that glia cells have more exosome uptake
than neurons [116]. All these studies demonstrate that the exosome

uptake efficiency depends on cell types and cell-surface receptors. More
related mechanisms should be elucidated in future studies to better
understand the uptake, internalization, and traffic processes of
exosomes.
MSC derived exosomes retain most characteristics of their parent
cells, such as the promotion of neurite outgrowth and angiogenesis,
immunomodulation, and the ability to repair damaged tissue [117,118].
Exosomal miRNAs play important roles in mediating these physiologic
and therapeutic effects [119].
Our miRNA sequencing results demonstrated that the exosomes and
their parent hADMSCs displayed different miRNA features. hADMSCSCs and their dExo had many similar miRNA components, whereas
many miRNAs were detected in hADMSCs but not in uExo. This also
demonstrates that hADMSC-SCs may be a better source for exosome
isolation. Most importantly, miRNA profiling analysis also revealed that
many miRNAs were significantly upregulated in dExo compared to those
in uExo. This may explain why dExo had enhanced activities and func
tions on the tested peripheral nerve-related cells. Among various
differentially expressed miRNAs, we focused on miRNA-132-3p and
miRNA-199b-5p, which had high reads and significant fold changes. As
previously reported, miRNA-132 is related to regulating neuronal dif
ferentiation, maturation, and function [120]. miRNA-132 over
expression in SCs significantly promoted cellular migration after sciatic
nerve injury by targeting at PRKAG3 [121]. miRNA-132 can also regu
late the target gene RASA1 in neuronal function to promote mouse DRG
axon extension [122]. It can also regulate the vascular integrity of the
brain for neurovascular communication [123]. The miRNA-132-3p
target network analysis indicated that several important signaling
pathways, including the neurotrophin signaling pathway, axon guid
ance, VEGF signaling pathway, and TGF-β signaling pathway, were
activated, which may explain why axon growth and angiogenesis were
promoted after the treatment with dExo. miRNA-199b-5p, on the other
hand, has been reported to attenuate the inflammatory response through
the GSK3β/NF-κB signaling pathways in monocytes [124]. In another
study, when miRNA-199b-5p was upregulated, the inflammatory
response could be suppressed by the regulation of the IκB kinase β
(IKKβ)//NF-κB pathway in LPS-activated microglia [125]. In the present
study, we found the upregulation of miRNA-199b-5p in dExo, and this
may be reason for the decrease of pro-inflammatory gene expression and
cytokine secretion. Additionally, miRNA network analysis results
showed that the TNF signaling pathway, mTOR signaling pathway, and
Notch signaling pathway, which are all related to neuroinflammation
and oxidative stress, are regulated by miRNA-199b-5p. Inflammatory
response is known to be beneficial for the recovery and regeneration of
injured tissue during the acute stage. However, an overactive and
chronic inflammatory response can lead to secondary damage. In this
study, dExo, containing miRNA-199b-5p, might be able to regulate
several signaling pathways with anti-inflammatory abilities to protect
the growth and function of neuron-related cells. In another study,
Lopez-Leal et al. reprogrammed rat SCs into repair SC phenotype and
demonstrated that SC reprogramming upregulated exosomal miRNA-21
to promote neurite growth [126]. In current study, we also found that
miRNA-21-5p expressed high levels in all the uExo, dExo, hADMSC and
hADMSC-SC groups. Moreover, miRNA-21-5p was significantly upre
gulated (p = 4.24E-03, log 2 (fold change) = 1.53) in the hADMSC-SC
group compared to hADMSC group, but no significance difference be
tween uExo and dExo groups. It is possible that miR-21-5p might also
contribute to axonal growth. In this study, we differentiated hADMSCs
to SC phenotypes with more capacity for myelinating rather than
repairing. This may explain why miRNA-21 expression was similar for
uExo and dExo groups.
5. Conclusion
In summary, we successfully differentiated hADMSCs towards the SC
phenotype and demonstrated that the hADMSC-SCs secreted much more
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growth factors and neurotrophic factors compared to hADMSCs without
differentiation. We further isolated uExo and dExo from hADMSCs and
hADMSC-SCs, respectively. We demonstrated that all these exosomes
can be captured by various peripheral nerve-related cells, like SCs,
endothelial cells, macrophages, and neurons, and can be effectively
internalized in HUVECs. We also showed that dExo improved the ROS
scavenging capacity and promoted rSC proliferation in the early stage
(day 1 and day 3). The dExo also facilitated the angiogenesis of HUVECs
and significantly downregulated pro-inflammatory gene expressions and
cytokine secretions of M1 macrophages. The axonal growth of hiPSCSNs was significantly enhanced by dExo treatment. Furthermore,
miRNA sequencing analysis unveiled that hADMSC-derived exosomes
and their parent cells shared some similarity of their miRNA profiles,
and dExo contained much more miRNA compared to uExo. Several
upregulated miRNAs in dExo, like miRNA-132-3p and miRNA-199b-5p,
are highly related to neuroprotection, angiogenesis, and neuroimmune
modulation. Based on the combination of hADMSC and SC features,
dExo is a promising cell-free biological therapeutic for promoting neural
regeneration because it effectively targets various peripheral nerverelated cells. Future studies may focus more on the efficacy of dExo on
neuroprotection and neural regeneration in vivo and on understanding
deeper insights of specific miRNA cargo(s).
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